Table 2.
Manually extracted imaging features from radiogenomic studies
| Study | Modality | Cancer | Significance definition | Manually extracted feature |
|---|---|---|---|---|
| Jamshidi et al28 | CT | CCRCC | Association with gene clusters | Pattern of tumour necrosis, tumour transition zone, tumour–parenchyma interaction, tumour–parenchyma interface |
| Kuo et al18 | CT | HCC | Association with mRNA and gene clusters | Internal arteries, texture heterogeneity, wash-in, washout, necrosis, tumour margin score |
| Segal et al20 | CT | HCC | Association with mRNA | Necrosis, internal septa, texture heterogeneity (arterial and venous phase), tumour margin score (minimum and maximum), enhancement pattern, internal arteries (density and necrosis edge), hypodense halo, washout, internal arteries (density), tumour–liver difference, corrected imaging area, necrosis density, capsule, wash-in, infiltration, tumour–liver difference, attenuation/heterogeneity score |
| Carlson et al24 | CT | HGG | Association with mRNA | Oedema |
| Gevaert et al15 | CT | NSCLC | Association with mRNA | Internal air bronchogram, complex shape, vascular convergence, lobulated margin, oval shape, irregular margin, pleural retraction, solid density, entering airway, right upper lobe apical location |
| Aerts et al9 | CT | NSCLC | Association with mRNA | None |
| Jain et al32 | CT | GBM | Association with mRNA | None |
| Osborne et al36 | PET | Breast cancer | Association with molecular subtypes | None |
| Palaskas et al37 | PET | Breast cancer | Association with Myc-overexpression | None |
| Nair et al19 | PET | NSCLC | Association with mRNA and gene clusters | None |
| Yamamoto et al21 | MRI | Breast cancer | Association with gene clusters | Enhancement pattern, size, shape, margin, location, T2 tumour signal interface between tissue and tumour, satellite lesions, multifocal disease, lymph node involvement, un-coordinated growth, stromal alterations |
| Yamamoto et al22 | MRI | Breast cancer | Association with IncRNA | None |
| Zhu et al38 | MRI | Breast cancer | Association with gene clusters | None |
| Halle et al40 | MRI | Cervical cancer | Association with gene clusters | None |
| Gevaert et al16 | MRI | GBM | Association with molecular subtypes | VASARI (deep white matter location, enhancement, enhancing margin characteristics, diffusion characteristics) |
| Colen et al29 | MRI | GBM | Association with mRNA | VASARI (enhancing tumour across midline/corpus callosum, deep white matter tract involvement, ependymal involvement) |
| Nicolasjilwan et al34 | MRI | GBM | Association with mRNA and CNV | VASARI (proportion of tumour contrast enhancement) |
| Jamshidi et al17 | MRI | GBM | Association with gene clusters | Contrast enhancement, necrosis, contrast-to-necrosis ratio, infiltrative vs oedematous T2abnormality, mass effect, subventricular zone involvement |
| Barajas et al24 | MRI | GBM | Association with mRNA and gene clusters | Lesion location, presence of contrast enhancement, central necrosis, degree of T2 oedema, mass effect |
| Diehn et al25 | MRI | GBM | Association with gene clusters | Contrast enhancement, necrosis, mass effect, pattern of T2oedema (infiltrative/oedematous), cortical involvement, SVZ involvement, C : N ratio, contrast/T2 ratio, degree of T2 oedema, T2 heterogeneity |
| Pope et al26 | MRI | GBM | Association with mRNA | Enhancement extent |
| Zinn et al23 | MRI | GBM | Association with mRNA and micro-RNA | None |
| Zinn et al27 | MRI | GBM | Association with mRNA and micro-RNA | None |
| Colen et al31 | MRI | GBM | Association with mRNA and micro-RNA | None |
| Naeini et al33 | MRI | GBM | Association with molecular subtypes | None |
| Pope et al35 | MRI | GBM | Association with mRNA | None |
| Miura et al39 | MRI | HCC | Association with mRNA | Intensity on hepatobiliary phase |
CCRCC, clear-cell renal cell carcinoma; C:N ratio, contrast:necrosis ratio; CNV, copy number variation; GBM, glioblastoma multiforme; HCC, hepatocellular carcinoma; HGG, high-grade glioma; mRNA, messenger RNA; NSCLC, non-small-cell lung cancer; PET, positron emission tomography; SVZ, subventricular zone; VASARI, Visually Accessible Rembrandt Images.
Bold type means significant relationship of imaging feature with genomic data.